Imugene Limited: ASX Small and Mid Cap Conference March 2024

The ASX Small and Mid-Cap Conference provides investors with a unique opportunity to hear from emerging leaders across a broad range of ASX-listed small and mid-cap companies. Watch this video to hear from Dr Nick Ede, Head of Corporate Development at Imugene Ltd.
#ASX #smallcaps #biotech #immunoOncology #cancertreatment #biotechnology #cancerresearch #investing

[@shanea9613]

Amazing technology. I hope it all works out

[@73maxoneit]

As stage 4 patient I hope you will move quickly!